Literature DB >> 28839828

Transoral oesophagogastric fundoplication is effective in treating proton pump inhibitor-resistant regurgitation.

Philip Hendy.   

Abstract

Keywords:  DYSPEPSIA; ENDOSCOPIC PROCEDURES; ENDOSCOPY

Year:  2015        PMID： 28839828      PMCID： PMC5369517          DOI： 10.1136/flgastro-2015-100586

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN： 2041-4137


× No keyword cloud information.
  5 in total

1.  Long-term cost-effectiveness of medical, endoscopic and surgical management of gastroesophageal reflux disease.

Authors:  Luke M Funk; James Y Zhang; Joseph M Drosdeck; W Scott Melvin; John P Walker; Kyle A Perry
Journal:  Surgery       Date:  2014-09-26       Impact factor: 3.982

2.  Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.

Authors:  Peter J Kahrilas; Andreas Jonsson; Hans Denison; Börje Wernersson; Nesta Hughes; Colin W Howden
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 11.382

3.  Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.

Authors:  John G Hunter; Peter J Kahrilas; Reginald C W Bell; Erik B Wilson; Karim S Trad; James P Dolan; Kyle A Perry; Brant K Oelschlager; Nathaniel J Soper; Brad E Snyder; Miguel A Burch; William Scott Melvin; Kevin M Reavis; Daniel G Turgeon; Eric S Hungness; Brian S Diggs
Journal:  Gastroenterology       Date:  2014-10-13       Impact factor: 22.682

4.  Determining an appropriate threshold for referral to surgery for gastroesophageal reflux disease.

Authors:  Jean Y Liu; Samuel R G Finlayson; William S Laycock; Richard I Rothstein; Thadeus L Trus; Heiko Pohl; John D Birkmeyer
Journal:  Surgery       Date:  2003-01       Impact factor: 3.982

5.  Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO Randomized Clinical Trial.

Authors:  Karim S Trad; William E Barnes; Gilbert Simoni; Ahmad B Shughoury; Peter G Mavrelis; Mamoon Raza; Jeffrey A Heise; Daniel G Turgeon; Mark A Fox
Journal:  Surg Innov       Date:  2014-04-21       Impact factor: 2.058
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.